Trial Profile
An Open Label, Single-dose Study to Evaluate the Pharmacokinetics, Metabolism and Excretion Balance of [14C]-ONO-4053 in Healthy Adult Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2014
Price :
$35
*
At a glance
- Drugs ONO 4053 (Primary)
- Indications Allergic rhinitis; Seasonal allergic rhinitis
- Focus Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 14 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Aug 2013 New trial record